vs

Side-by-side financial comparison of KINGSWAY FINANCIAL SERVICES INC (KFS) and Theravance Biopharma, Inc. (TBPH). Click either name above to swap in a different company.

Theravance Biopharma, Inc. is the larger business by last-quarter revenue ($45.9M vs $38.6M, roughly 1.2× KINGSWAY FINANCIAL SERVICES INC). Theravance Biopharma, Inc. runs the higher net margin — 133.0% vs -4.1%, a 137.1% gap on every dollar of revenue. On growth, Theravance Biopharma, Inc. posted the faster year-over-year revenue change (144.7% vs 30.1%). Over the past eight quarters, Theravance Biopharma, Inc.'s revenue compounded faster (77.9% CAGR vs 21.4%).

Kingsway Financial Services Inc. is a specialty financial holding firm that primarily offers property and casualty insurance products, including personal auto, commercial liability and property coverage. It operates mainly across North American markets, catering to individual consumers, small business owners and niche commercial client segments.

Theravance Biopharma, Inc. is a global biopharmaceutical enterprise focused on researching, developing and commercializing innovative medicines for patients with serious, unmet medical needs, primarily targeting respiratory and infectious disease segments. It operates core markets across North America and Europe, partnering with global healthcare stakeholders to advance its therapy pipeline and deliver effective, accessible treatment options to underserved patient groups.

KFS vs TBPH — Head-to-Head

Bigger by revenue
TBPH
TBPH
1.2× larger
TBPH
$45.9M
$38.6M
KFS
Growing faster (revenue YoY)
TBPH
TBPH
+114.6% gap
TBPH
144.7%
30.1%
KFS
Higher net margin
TBPH
TBPH
137.1% more per $
TBPH
133.0%
-4.1%
KFS
Faster 2-yr revenue CAGR
TBPH
TBPH
Annualised
TBPH
77.9%
21.4%
KFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KFS
KFS
TBPH
TBPH
Revenue
$38.6M
$45.9M
Net Profit
$-1.6M
$61.0M
Gross Margin
Operating Margin
0.8%
43.6%
Net Margin
-4.1%
133.0%
Revenue YoY
30.1%
144.7%
Net Profit YoY
-7.8%
493.0%
EPS (diluted)
$-0.07
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KFS
KFS
TBPH
TBPH
Q4 25
$38.6M
$45.9M
Q3 25
$37.2M
$20.0M
Q2 25
$30.9M
$26.2M
Q1 25
$28.3M
$15.4M
Q4 24
$29.6M
$18.8M
Q3 24
$27.1M
$16.9M
Q2 24
$26.4M
$14.3M
Q1 24
$26.2M
$14.5M
Net Profit
KFS
KFS
TBPH
TBPH
Q4 25
$-1.6M
$61.0M
Q3 25
$-2.4M
$3.6M
Q2 25
$-3.2M
$54.8M
Q1 25
$-3.1M
$-13.6M
Q4 24
$-1.5M
$-15.5M
Q3 24
$-2.3M
$-12.7M
Q2 24
$-2.2M
$-16.5M
Q1 24
$-2.3M
$-11.7M
Operating Margin
KFS
KFS
TBPH
TBPH
Q4 25
0.8%
43.6%
Q3 25
-2.3%
-32.3%
Q2 25
-3.6%
-10.4%
Q1 25
-2.5%
-93.8%
Q4 24
6.5%
-49.1%
Q3 24
-2.5%
-64.2%
Q2 24
0.5%
-110.2%
Q1 24
2.9%
-77.3%
Net Margin
KFS
KFS
TBPH
TBPH
Q4 25
-4.1%
133.0%
Q3 25
-6.5%
18.1%
Q2 25
-10.2%
209.3%
Q1 25
-10.9%
-88.2%
Q4 24
-5.0%
-82.8%
Q3 24
-8.5%
-75.3%
Q2 24
-8.3%
-115.9%
Q1 24
-8.9%
-80.4%
EPS (diluted)
KFS
KFS
TBPH
TBPH
Q4 25
$-0.07
$1.18
Q3 25
$-0.10
$0.07
Q2 25
$-0.13
$1.08
Q1 25
$-0.13
$-0.27
Q4 24
$-0.08
$-0.31
Q3 24
$-0.10
$-0.26
Q2 24
$-0.08
$-0.34
Q1 24
$-0.09
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KFS
KFS
TBPH
TBPH
Cash + ST InvestmentsLiquidity on hand
$8.5M
$167.8M
Total DebtLower is stronger
$70.7M
Stockholders' EquityBook value
$15.2M
$296.7M
Total Assets
$231.5M
$485.6M
Debt / EquityLower = less leverage
4.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KFS
KFS
TBPH
TBPH
Q4 25
$8.5M
$167.8M
Q3 25
$9.5M
$174.8M
Q2 25
$12.3M
$281.9M
Q1 25
$6.5M
$110.6M
Q4 24
$5.7M
$37.8M
Q3 24
$6.7M
$23.4M
Q2 24
$9.8M
$46.3M
Q1 24
$12.3M
$53.8M
Total Debt
KFS
KFS
TBPH
TBPH
Q4 25
$70.7M
Q3 25
$70.7M
Q2 25
$58.3M
Q1 25
$59.5M
Q4 24
$57.5M
Q3 24
$58.5M
Q2 24
$47.3M
Q1 24
$47.1M
Stockholders' Equity
KFS
KFS
TBPH
TBPH
Q4 25
$15.2M
$296.7M
Q3 25
$16.6M
$232.7M
Q2 25
$17.4M
$224.8M
Q1 25
$5.5M
$166.0M
Q4 24
$8.4M
$175.5M
Q3 24
$9.9M
$185.7M
Q2 24
$20.7M
$193.7M
Q1 24
$23.6M
$204.9M
Total Assets
KFS
KFS
TBPH
TBPH
Q4 25
$231.5M
$485.6M
Q3 25
$235.1M
$415.5M
Q2 25
$207.7M
$426.0M
Q1 25
$192.1M
$343.6M
Q4 24
$186.6M
$354.2M
Q3 24
$191.1M
$356.1M
Q2 24
$192.3M
$362.0M
Q1 24
$198.0M
$371.3M
Debt / Equity
KFS
KFS
TBPH
TBPH
Q4 25
4.66×
Q3 25
4.25×
Q2 25
3.34×
Q1 25
10.91×
Q4 24
6.84×
Q3 24
5.88×
Q2 24
2.29×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KFS
KFS
TBPH
TBPH
Operating Cash FlowLast quarter
$-3.0K
$-6.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.10×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KFS
KFS
TBPH
TBPH
Q4 25
$-3.0K
$-6.1M
Q3 25
$1.5M
$-6.5M
Q2 25
$337.0K
$208.1M
Q1 25
$-1.8M
$43.0M
Q4 24
$1.1M
$-902.0K
Q3 24
$368.0K
$-5.2M
Q2 24
$557.0K
$-4.4M
Q1 24
$249.0K
$-1.0M
Free Cash Flow
KFS
KFS
TBPH
TBPH
Q4 25
Q3 25
$1.3M
Q2 25
Q1 25
Q4 24
$-1.1M
Q3 24
$-5.2M
Q2 24
$-4.5M
Q1 24
$-1.1M
FCF Margin
KFS
KFS
TBPH
TBPH
Q4 25
Q3 25
3.4%
Q2 25
Q1 25
Q4 24
-5.8%
Q3 24
-30.9%
Q2 24
-31.2%
Q1 24
-7.7%
Capex Intensity
KFS
KFS
TBPH
TBPH
Q4 25
Q3 25
0.5%
0.0%
Q2 25
Q1 25
Q4 24
1.0%
Q3 24
0.0%
0.1%
Q2 24
0.3%
Q1 24
0.6%
Cash Conversion
KFS
KFS
TBPH
TBPH
Q4 25
-0.10×
Q3 25
-1.80×
Q2 25
3.79×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KFS
KFS

Other$14.8M38%
Roundhouse Electric Equipment Co Inc$9.7M25%
MLC Plumbing LLC$5.7M15%
Systems Products International Incspi$3.8M10%
Advanced Plumbing And Drain$2.9M8%
Southside Plumbing$1.7M4%

TBPH
TBPH

Segment breakdown not available.

Related Comparisons